|
|
501 Fifth Street
Bristol, TN 37620 USA
phone:(423) 989-8000
fax:(866) 990-0545
|
|
| Symbol |
KG |
| Exchange |
NYSE |
| Founded |
1994 |
| Employees |
2997 |
|
|
| www.kingpharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Branded prescription pharmaceutical products. |
|
| Management |
| Brian Markison, CEO; Joseph Squicciarino, CFO; Eric J. Bruce, CTO; Mark J.J. van Haaren, Manager Business |
| |
|
|
|
|
|
|
|
| Keywords |
| oxycodone, pharmaceutical, unmet need, clinical development, drug safety |
|
|
|
| Description |
|
King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that develops manufactures, markets and sells branded prescription pharmaceutical products. |
|
| Products / Services |
The Company's branded pharmaceutical products can be divided primarily into the cardiovascular (including Altace, Corzide, Procanbid and Thalitone); endocrinology/women's health (including Levoxyl, Cytomel, Triostat, Prefest, Menest, Delestrogen and Nordette); orthopedic (Skelaxin); critical care (including Thrombin-JMI, Brevital and Synercid); neurology/central nervous system (Sonata); anti-infectives (including Bicillin, Cortisporin, Neosporin and Coly-Mycin M); respiratory (including Intal and Tilade), and biodefense (Atropen and ComboPen) therapeutic areas.
|
|
| Market / Customers |
King markets its branded pharmaceutical products to general/family practitioners, internal medicine physicians, cardiologists, endocrinologists, obstetrician/gynecologists and hospitals across the United States and in Puerto Rico.
|
|
| Competitors / Substitutes / Alternatives |
Forest Laboratories Inc (FRX); Valeant Pharmaceuticals International (VRX); Watson Pharmaceuticals Inc (WPI)
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
